294 related articles for article (PubMed ID: 18706868)
1. Temocillin in cystic fibrosis: a retrospective pilot study.
Kent L; Bradley JM; France M; Döring G; Carryn S; Bradbury I; Rendall J; Jones A; Elborn JS
J Cyst Fibros; 2008 Nov; 7(6):551-4. PubMed ID: 18706868
[TBL] [Abstract][Full Text] [Related]
2. Temocillin in the treatment of Burkholderia cepacia infection in cystic fibrosis.
Lekkas A; Gyi KM; Hodson ME
J Cyst Fibros; 2006 May; 5(2):121-4. PubMed ID: 16650744
[TBL] [Abstract][Full Text] [Related]
3. Changes in lung function in young cystic fibrosis patients between two courses of intravenous antibiotics against Pseudomonas aeruginosa.
Béghin L; Michaud L; Loeuille GA; Wizla-Derambure N; Sayah H; Sardet A; Thumerelle C; Deschildre A; Turck D; Gottrand F
Pediatr Pulmonol; 2009 May; 44(5):464-71. PubMed ID: 19360849
[TBL] [Abstract][Full Text] [Related]
4. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.
Knudsen PK; Olesen HV; Høiby N; Johannesson M; Karpati F; Laerum BN; Meyer P; Pressler T; Lindblad A;
J Cyst Fibros; 2009 Mar; 8(2):135-42. PubMed ID: 19157995
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of home treatment for patients with cystic fibrosis: the intravenous administration of antibiotics to treat respiratory infections.
Termoz A; Touzet S; Bourdy S; Decullier E; Bouveret L; Colin C; Nove-Josserand R; Reix P; Cracowski C; Pin I; Bellon G; Durieu I
Pediatr Pulmonol; 2008 Sep; 43(9):908-15. PubMed ID: 18680182
[TBL] [Abstract][Full Text] [Related]
6. Sputum antibiotic concentrations: implications for treatment of cystic fibrosis lung infection.
Moriarty TF; McElnay JC; Elborn JS; Tunney MM
Pediatr Pulmonol; 2007 Nov; 42(11):1008-17. PubMed ID: 17902147
[TBL] [Abstract][Full Text] [Related]
7. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
Hansen CR; Pressler T; Høiby N
J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
[TBL] [Abstract][Full Text] [Related]
8. Nebulized tobramycin in the treatment of adult CF pulmonary exacerbations.
Al-Aloul M; Nazareth D; Walshaw M
J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):299-305. PubMed ID: 24219814
[TBL] [Abstract][Full Text] [Related]
9. Implementation of European standards of care for cystic fibrosis--control and treatment of infection.
Elborn JS; Hodson M; Bertram C
J Cyst Fibros; 2009 May; 8(3):211-7. PubMed ID: 19372063
[TBL] [Abstract][Full Text] [Related]
10. Predictors of mortality in adults with cystic fibrosis.
Courtney JM; Bradley J; Mccaughan J; O'Connor TM; Shortt C; Bredin CP; Bradbury I; Elborn JS
Pediatr Pulmonol; 2007 Jun; 42(6):525-32. PubMed ID: 17469153
[TBL] [Abstract][Full Text] [Related]
11. [Antibiotic therapy and effects of respiratory physiotherapy techniques in cystic fibrosis patients treated for acute lung exacerbations: an experimental study].
da Silva Santos CI; Gonçalves de Oliveira Ribeiro MA; Moreno Morcillo A; Fernando Ribeiro A; Dirceu Ribeiro J
Arch Bronconeumol; 2010 Jun; 46(6):310-6. PubMed ID: 20417019
[TBL] [Abstract][Full Text] [Related]
12. Comparison of hospital and home intravenous antibiotic therapy in adults with cystic fibrosis.
Esmond G; Butler M; McCormack AM
J Clin Nurs; 2006 Jan; 15(1):52-60. PubMed ID: 16390524
[TBL] [Abstract][Full Text] [Related]
13. Temocillin and cystic fibrosis: outcome of intravenous administration in patients infected with Pseudomonas cepacia.
Taylor RF; Gaya H; Hodson ME
J Antimicrob Chemother; 1992 Mar; 29(3):341-4. PubMed ID: 1375595
[TBL] [Abstract][Full Text] [Related]
14. Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use.
Al-Aloul M; Miller H; Alapati S; Stockton PA; Ledson MJ; Walshaw MJ
Pediatr Pulmonol; 2005 Jan; 39(1):15-20. PubMed ID: 15521084
[TBL] [Abstract][Full Text] [Related]
15. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance.
De Baets F; Schelstraete P; Van Daele S; Haerynck F; Vaneechoutte M
J Cyst Fibros; 2007 Jan; 6(1):75-8. PubMed ID: 16793350
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary infection in mild variant cystic fibrosis: implications for care.
Lording A; McGaw J; Dalton A; Beal G; Everard M; Taylor CJ
J Cyst Fibros; 2006 May; 5(2):101-4. PubMed ID: 16426904
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic use in cystic fibrosis.
Eisenberg JD
Curr Opin Pulm Med; 1996 Nov; 2(6):439-46. PubMed ID: 9363182
[TBL] [Abstract][Full Text] [Related]
18. Long-term benefits of inhaled tobramycin in children with cystic fibrosis: first clinical observations from Poland.
Stelmach I; Korzeniewska A; Stelmach W
Respiration; 2008; 75(2):178-81. PubMed ID: 17435382
[TBL] [Abstract][Full Text] [Related]
19. The approach to Pseudomonas aeruginosa in cystic fibrosis.
Bendiak GN; Ratjen F
Semin Respir Crit Care Med; 2009 Oct; 30(5):587-95. PubMed ID: 19760546
[TBL] [Abstract][Full Text] [Related]
20. In vitro interactions of tobramycin with various nonantibiotics against Pseudomonas aeruginosa and Burkholderia cenocepacia.
Treerat P; Widmer F; Middleton PG; Iredell J; George AM
FEMS Microbiol Lett; 2008 Aug; 285(1):40-50. PubMed ID: 18513356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
